Target intelligence / Profile preview

Bcl-2-like protein 11 mRNA 3' untranslated region (BIM mRNA 3'UTR)

Target
BIM mRNA 3'UTR
Molecular classification
RNA, Untranslated region, Regulatory RNA element
01

Overview

The Bcl-2-like protein 11 (BIM) mRNA 3' untranslated region (3'UTR) is a critical regulatory segment of the messenger RNA encoding the pro-apoptotic protein BIM (UniProt O43521). As a BH3-only member of the BCL-2 family, BIM is a central initiator of the intrinsic apoptotic pathway, neutralizing anti-apoptotic proteins to trigger mitochondrial outer membrane permeabilization (PubMed: 22856430). The 3'UTR serves as a hub for post-transcriptional control, containing numerous binding sites for oncogenic microRNAs—such as the miR-17-92 cluster, miR-221, and miR-24—and RNA-binding proteins like DND1 that dictate mRNA stability and translation efficiency (PubMed: 23135145, 28611294). In many cancers, BIM is downregulated through the overexpression of these miRNAs, which leads to apoptosis resistance and survival of malignant cells, particularly in response to tyrosine kinase inhibitors (PubMed: 22856430). Therapeutic strategies targeting the BIM 3'UTR, including antisense oligonucleotides (ASOs) and antagomirs, aim to block miRNA-mediated repression, thereby restoring BIM expression and sensitizing tumors to programmed cell death (PubMed: 30185415).

Other names
BCL2L11 3'UTRBIM 3-prime untranslated regionBIM 3' untranslated regionBcl-2-like protein 11 3'UTR
02

Mechanism of action

Modulation of BIM protein levels by blocking microRNA-mediated degradation or translational inhibition to restore apoptotic sensitivity.

03

Biological functions

Apoptosis regulationmRNA stabilityTranslational regulationPost-transcriptional gene regulation
04

Disease associations

CancerAutoimmune diseaseDrug resistanceNeurodegenerative disease
05

Safety considerations

Off-target RNA bindingSystemic pro-apoptotic toxicityDelivery challenges for RNA therapeutics
06

Interacting drugs

Antisense oligonucleotides

3 more in the full profile.

07

Biomarkers

BIM mRNA levelsBIM protein levelsmiR-17-92 expressionBIM deletion polymorphism

Beyond the preview

Go deeper on Bcl-2-like protein 11 mRNA 3' untranslated region (BIM mRNA 3'UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bcl-2-like protein 11 mRNA 3' untranslated region (BIM mRNA 3'UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call